These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 8364870)
1. DNA flow cytometry and pathologic grading as prognostic guides in axillary lymph node-negative breast cancer. Merkel DE; Winchester DJ; Goldschmidt RA; August CZ; Wruck DM; Rademaker AW Cancer; 1993 Sep; 72(6):1926-32. PubMed ID: 8364870 [TBL] [Abstract][Full Text] [Related]
2. DNA flow cytometric analysis and prognosis of axillary lymph node-negative breast carcinoma. Bosari S; Lee AK; Tahan SR; Figoni MA; Wiley BD; Heatley GJ; Silverman ML Cancer; 1992 Oct; 70(7):1943-50. PubMed ID: 1525770 [TBL] [Abstract][Full Text] [Related]
3. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer. Meyer JS; Province MA Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981 [TBL] [Abstract][Full Text] [Related]
4. Two-color, cytokeratin-labeled dna flow cytometric analysis of 332 breast cancers: lack of prognostic value with 12-year follow-up. Prasad AR; Divine G; Zarbo RJ Arch Pathol Lab Med; 2001 Mar; 125(3):364-74. PubMed ID: 11231485 [TBL] [Abstract][Full Text] [Related]
5. DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients. Pinto AE; Pereira T; Santos M; Branco M; Dias A; Silva GL; Ferreira MC; André S Ann Surg Oncol; 2013 May; 20(5):1530-7. PubMed ID: 23250736 [TBL] [Abstract][Full Text] [Related]
6. S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer - a multivariate study of 770 patients. Gazic B; Pizem J; Bracko M; Cufer T; Borstnar S; Pohar-Marinsek Z; Us-Krasovec M Cytopathology; 2008 Oct; 19(5):294-302. PubMed ID: 18070112 [TBL] [Abstract][Full Text] [Related]
7. Mammographic growth rate, DNA ploidy, and S-phase fraction analysis in breast carcinoma. A prognostic evaluation in a screened population. Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA Cancer; 1992 Oct; 70(7):1935-42. PubMed ID: 1525769 [TBL] [Abstract][Full Text] [Related]
8. Prognostic value of histologic grade and proliferative activity in axillary node-positive breast cancer: results from the Eastern Cooperative Oncology Group Companion Study, EST 4189. Simpson JF; Gray R; Dressler LG; Cobau CD; Falkson CI; Gilchrist KW; Pandya KJ; Page DL; Robert NJ J Clin Oncol; 2000 May; 18(10):2059-69. PubMed ID: 10811671 [TBL] [Abstract][Full Text] [Related]
9. Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: analysis of a series of 271 patients with stage I and II breast cancer. Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J Breast Cancer Res Treat; 2005 May; 91(1):61-71. PubMed ID: 15868432 [TBL] [Abstract][Full Text] [Related]
10. [Combined flow cytometry determination of S-phase fraction and DNA ploidy is an independent prognostic factor in node-negative invasive breast carcinoma: review of a series of 271 patients with stage I and II breast cancer]. Moureau-Zabotto L; Bouchet C; Cesari D; Uzan S; Lefranc JP; Antoine M; Genestie C; Deniaud-Alexandre E; Bernaudin JF; Touboul E; Fleury-Feith J Cancer Radiother; 2005 Dec; 9(8):575-86. PubMed ID: 16243560 [TBL] [Abstract][Full Text] [Related]
11. The value of S-phase and DNA ploidy analysis as prognostic markers for node-negative breast cancer in the Australian setting. Wong SW; Rangan AM; Bilous AM; Boyages J; Gebski V; Benson EM Pathology; 1999 May; 31(2):90-4. PubMed ID: 10399161 [TBL] [Abstract][Full Text] [Related]
12. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: a standardized flow cytometric study. Chassevent A; Jourdan ML; Romain S; Descotes F; Colonna M; Martin PM; Bolla M; Spyratos F Clin Cancer Res; 2001 Apr; 7(4):909-17. PubMed ID: 11309341 [TBL] [Abstract][Full Text] [Related]
13. S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic grade in a prospective study of premenopausal lymph node-negative breast cancer. Malmström P; Bendahl PO; Boiesen P; Brünner N; Idvall I; Fernö M; J Clin Oncol; 2001 Apr; 19(7):2010-9. PubMed ID: 11283134 [TBL] [Abstract][Full Text] [Related]
14. Flow cytometry in breast cancer: prognostic and surgical indications of the sparing of axillary lymph node dissection. Zanon C; Durando A; Geuna M; Clara R; Mobiglia A; Massobrio M; Palestro G; Pourshayesteh A Am J Clin Oncol; 1998 Aug; 21(4):392-7. PubMed ID: 9708640 [TBL] [Abstract][Full Text] [Related]
15. Breast carcinoma growth rate described by mammographic doubling time and S-phase fraction. Correlations to clinical and histopathologic factors in a screened population. Arnerlöv C; Emdin SO; Lundgren B; Roos G; Söderström J; Bjersing L; Norberg C; Angquist KA Cancer; 1992 Oct; 70(7):1928-34. PubMed ID: 1525768 [TBL] [Abstract][Full Text] [Related]
16. Evaluation and reinforcement of the correlation of S-phase fraction with nodal metastases, tumor grade and tumor size in breast carcinoma patients in Pakistan. Bakhtawar H; Ali NM; Khan S; Aziz SA; Sliddiqui T; Pervez S Pathol Res Pract; 2001; 197(8):531-6. PubMed ID: 11518045 [TBL] [Abstract][Full Text] [Related]
17. Prognostic potential of flow cytometric S-phase and ploidy prospectively determined in primary breast carcinomas. Ewers SB; Attewell R; Baldetorp B; Borg A; Långström E; Killander D Breast Cancer Res Treat; 1992 Jan; 20(2):93-108. PubMed ID: 1554892 [TBL] [Abstract][Full Text] [Related]
18. Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients. Pinto AE; André S; Soares J J Clin Pathol; 1999 Aug; 52(8):604-11. PubMed ID: 10645231 [TBL] [Abstract][Full Text] [Related]
19. Flow cytometric DNA content analysis of 185 soft tissue neoplasms indicates that S-phase fraction is a prognostic factor for sarcomas. French Federation of Cancer Centers (FNCLCC) Sarcoma Group. Collin F; Chassevent A; Bonichon F; Bertrand G; Terrier P; Coindra JM Cancer; 1997 Jun; 79(12):2371-9. PubMed ID: 9191525 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast. Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]